Agios Pharmaceuticals (AGIO) Gains from Sales and Divestitures (2012 - 2016)
Agios Pharmaceuticals (AGIO) reported Gains from Sales and Divestitures of $7500.0 for Q3 2016, down 11.99% on a YoY basis from $8522.0 in Q4 2015, and little changed quarter-over-quarter from $7500.0 in Q2 2016.
Agios Pharmaceuticals (AGIO) Gains from Sales and Divestitures (2012 - 2016) Analysis & Trends
Agios Pharmaceuticals has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $7500.0 in Q3 2016.
- For the quarter ending Q3 2016, Gains from Sales and Divestitures fell 11.99% year-over-year to $7500.0; the trailing twelve-month figure through Sep 2016 stood at $7500.0 (down 11.99% YoY), and the FY2015 full-year result was $8522.0, down 42.31% from the prior year.
- Gains from Sales and Divestitures for Q3 2016 stood at $7500.0, roughly flat from $7500.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $183713.0 in Q4 2012, with the low at $2841.0 in Q1 2015.
- Historically, Gains from Sales and Divestitures has averaged $44362.6 across 5 years, with a median of $8806.5 in 2014.
- Annual changes were most pronounced in 2014 — Gains from Sales and Divestitures tumbled 90.55% — and 2016, when it surged 32.02%.
- Agios Pharmaceuticals' Gains from Sales and Divestitures stood at $183713.0 in 2012, then dropped by 25.56% to $136758.0 in 2013, then plunged by 89.2% to $14773.0 in 2014, then tumbled by 42.31% to $8522.0 in 2015, then retreated by 11.99% to $7500.0 in 2016.
- The last three Gains from Sales and Divestitures figures came in at $7500.0 (Q3 2016), $7500.0 (Q2 2016), and $8522.0 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 7,500.00 |
| Sep 30, 2016 | 7,500.00 |
| Jun 30, 2016 | 7,500.00 |
| Jun 30, 2016 | 7,500.00 |
| Dec 31, 2015 | 8,522.00 |
| Dec 31, 2015 | 8,522.00 |
| Sep 30, 2015 | 8,522.00 |
| Sep 30, 2015 | 8,522.00 |
| Jun 30, 2015 | 5,681.00 |
| Jun 30, 2015 | 5,681.00 |
| Mar 31, 2015 | 2,841.00 |
| Mar 31, 2015 | 2,841.00 |
| Dec 31, 2014 | 14,773.00 |
| Dec 31, 2014 | 14,773.00 |
| Sep 30, 2014 | 11,932.00 |
| Sep 30, 2014 | 11,932.00 |
| Jun 30, 2014 | 9,091.00 |
| Jun 30, 2014 | 9,091.00 |
| Mar 31, 2014 | 4,545.00 |
| Mar 31, 2014 | 4,545.00 |